[What pharmaco-economic criteria should be considered when using glycopeptides].
Zambrowski
J-J
JJ
Service de médecine interne, faculté des sciences pharmaceutiques et biologiques, université René-Descartes-Paris-5, CHU Bichat AP-HP, Paris, France.
D000900:Anti-Bacterial Agents / Q000191:economics*; D017850:Economics, Pharmaceutical; D006020:Glycopeptides / Q000191:economics*
D000900:Anti-Bacterial Agents; D006020:Glycopeptides